Covanta Holding (CVA) Misses Q4 EPS by 5c
Tweet
Share
E-mail
Get Alerts CVA Hot Sheet
Price: $20.26 --0%
Financial Fact:
Covanta Holding Corporation: 0.42
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Covanta Holding Corporation: 0.42
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Covanta Holding (NYSE: CVA) reported Q4 EPS of $0.08, $0.05 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $457 million versus the consensus estimate of $425.49 million.
2017 GuidanceThe Company established guidance for 2017 for the following key metrics:
(In millions) | ||
Metric | 2016 Actual | 2017 Guidance Range (1) |
Adjusted EBITDA | $410 | $400 - $440 |
Free Cash Flow | $172 | $100 - $150 |
For earnings history and earnings-related data on Covanta Holding (CVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
- Legence Corp. (LGN) Misses Q2 EPS by 58c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
